Hamburg, Snyderman to Address Timely Issues in Personalized Medicine at 2015 Personalized Medicine World Conference in Silicon Valley

Reporter: Aviva Lev-Ari, PhD, RN

Margaret Hamburg, M.D.

FDA Commissioner

Ralph Snyderman, M.D.

Duke University Professor of Medicine

Hamburg will discuss:

• FDA’s efforts to promote personalized medicine
• FDA’s proposed framework to regulate laboratory-developed tests (LDTs)

On day two of the conference, PMC President Edward Abrahams will moderate the session titled “Risk, Reward and Innovation: The Economic Feasibility of Personalized Medicine” that will consider pricing options.

More than 100 additional speakers include George Church, Leroy Hood, Ira Klein, Michael Pellini, Kim Popovits, Craig Ventner, Jay Wohlgemuth and Anne Wojcicki, to name a few.

For the complete program go to: http://2015sv.pmwcintl.com/program.php

We look forward to seeing you in Mountain View. Don’t forget to visit us at PMC’s booth.

REGISTRATION

<http://pmwcintl.us3.list-manage.com/track/click?u=ae5d3f754afc0381fd85a57af&id=d6f4c4b92d&e=a27adfd7ff>

Contact information: team@pmwcintl.com

Announcement

LEADERS IN PHARMACEUTICAL BUSINESS INTELLIGENCE

will cover the event for the Media

Dr. Aviva Lev-Ari will be in attendance on January 26, 2015, 8:00AM to January 28, 2015, 3:30PM

Covering the Event in REALTIME using Social Media

 @PMWCintl 

#PMWC15

#startup #biotech #pharmanews @BiotechNews

@BloombergNews

@CancerNews

#Cancer Therapy

#science  #innovation @BloombergTV

&

Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com

The venture on Facebook
http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

on Twitter
@pharma_BI and @AVIVA1950

LinkedIn Group
http://www.linkedin.com/groups?gid=4346921&trk=hb_side_g

Dr. Lev-Ari, Top Contributor on Biotech Groups on LinkedIn 

http://www.linkedin.com/in/avivalevari